HEALTH
European drugmakers Sanofi and GSK strike $2.1 billion deal with U.S. for a coronavirus vaccine
HEALTH

European drugmakers Sanofi and GSK strike $2.1 billion deal with U.S. for a coronavirus vaccine

Published: July 31, 2020  |  3 min read, 597 words
WRITTEN BY
Your review will affect the following:
Please NoteThe Washington Post is providing this important information about the coronavirus for free. The federal government announced a $2.1 billion deal Friday with the French pharmaceutical company Sanofi and its British partner, GSK, to support the development of a vaccine the companies are working on together.The contract — the largest one yet from the U.S. government — includes the delivery of 100 million doses for the United States and is part of Operation Warp Speed, the Trump administration’s initiative to speed development of vaccines, treatments and diagnostics for the... READ MORE
CRITIC
washingtonpost.com
Outlet Rating
washingtonpost.com
img-trusted
77%
Critic Reviews: N/A
USER
washingtonpost.com
Outlet Rating
washingtonpost.com
img-trusted
68%
User Reviews: N/A
TOP REVIEWS
There are no reviews yet.

CRITIC REVIEWS

There don't seem to be any reviews yet.

PUBLIC REVIEWS

There don't seem to be any reviews yet.